November 21, 2014

Karen R. Effrem, MD EdWatch Board of Directors Alliance for Human Research Protection Board of Directors ICSPP

Read More
Testimony Against SF 2841-Minnesota – Preschool Socioemotional Screening–Karen Effrem, MD.

September 27, 2014

David Graham, MD, FDA’s Associate Director of Science and Medicine who, throughout his career, has been a

Read More
David Graham, MD

October 7, 2012

IV. What Do We Get for All That Money? According to the Kaiser Foundation:[1] The number of

Read More
America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

May 11, 2011

Antipsychotics are used primarily as chemical restraints to control behavior– not for any therapeutic, medically justifiable reason..

Read More
US Inspector General Report: Antipsychotic Drug Hazards

February 22, 2011

The FDA has just issued an alert to healthcare professionals–in particular, psychiatrists and obstetricians about the serious

Read More
FDA MedWatch- Antipsychotics Class Label Change

September 10, 2010

According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic

Read More
FDA Expands Market for Another Toxic Antipsychotic

July 15, 2010

In 2007, an FDA advisory panel voted 22 to 1 to keep GlaxoSmithKline’s diabetes drug, Avandia (Rosiglitazone)

Read More
Will Another Blockbuster Drug Hit the Dust?

June 13, 2010

A report in BNET, the business publication, by its pharmaceutical industry analyst, Jim Edwards, reveals that GlaxoSmithKline

Read More
Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks

March 17, 2010

The NY Times reports that an IMS Health report found that the giant pharmaceutical industry  annual growth

Read More
US Gov Medical Experiment Radically Departs from medical “Best Practices”

October 31, 2009

One of our very insightful professional Infomail readers suggested that our comments about who the antipsychotic drug

Read More
Follow-up: Antipsychotics–Psychiatry’s Disregard for the life-threatening hazards

April 29, 2009

If enacted, the IOM recommendations will essentially sever the financial ties that bind American medicine–its practitioners, researchers,

Read More
Institute of Medicine Calls for Doctors to Stop Taking Gifts From Drug Makers

April 20, 2009

ALLIANCE FOR HUMAN RESEARCH PROTECTION A catalyst for public debate 142 West End Avenue Suite 28P New

Read More
AHRP Letter to Harvard Re: Dr. Biederman’s Research

April 18, 2009

Upon receipt of a letter from Sen. Chuck Grassley, requesting disclosure of NAMI drug industry funding sources,

Read More
Culling the $$$ Evidence: National Alliance for Mental Illness